PharmacoEconomics & Outcomes News

, Volume 803, Issue 1, pp 13–13 | Cite as

Elbasvir/grazoprevir cost effective for hepatitis C in Italy

Clinical study


  1. Rolli FR, et al. Economic evaluation of Zepatier for the management of HCV in the Italian scenario. European Journal of Health Economics : 25 Apr 2018. Available from: URL:

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations